Mission possible – delivering translational impact is an international symposium organised together with the Finnish Cancer Institute. It will be held in Helsinki, Finland, on 25–26 September 2025. We expect around 300 participants to attend this multidisciplinary scientific event, which will bring together both clinical and experimental research experts.
Topics include: Translational clinical trials – Spatial Biology: biomarkers for precision oncology – Liquid biopsies – Translational tumor biology – AI in precision oncology
Programme
Venue
Little Finlandia
Located in the heart of Helsinki, the Little Finlandia (Karamzininranta 4, 00100 Helsinki) offers easy access and beautiful views of a scenic park and Töölönlahti Bay.
There are easy and frequent public transport connections from the airport, bus and train stations. Tram and bus stops are in the immediate vicinity of the house. Next to the Finlandia building there is a parking garage, Aimo Park, with the following lift connections: Karamzininranta 2 and the elevator hall of the Finlandia Hall building (closest to Little Finlandia). The drive to the parking garage takes place via Karamzininranta. Parking is available for a fee.
Dinner will be served at Hesperia Ballroom at the Crowne Plaza Helsinki (Mannerheimintie 50, 00260 Helsinki).
Registration
Registration: Registration and the waiting list are now closed. The symposium is currently at full capacity. For those on the waiting list, please note that we are exploring the possibility of increasing the number of participants. We’ll be reaching out next week to waitlisted participants, in the order registrations were received, if spots become available.
Symposium fees
Please note that a registration fee of 35€ is required from all the participants to attend the event. The registration fee covers two lunches, coffee breaks, and cloak room services during the symposium. A dinner fee of 30€ applies if you wish to join the dinner on 25.9.
For the sponsors, the registration and dinner fees are included in the sponsorship agreement.
Credits
The symposium is suitable as a theoretical course-based training in the fields of pathology, clinical hematology, and oncology, with a duration of 8 hours at the University of Helsinki. The training can also be included in the theoretical studies of a Doctor of Medicine or Doctor of Philosophy degree, corresponding to 0.7 ECTS credits.
Sponsors
The exhibition area will be located in the Little Finlandia foyer.
Organisers
Scientific Organizing Committee
Anniina Färkkilä (Chair), Assoc. Prof., University of Helsinki and Helsinki University Hospital
Sirpa Leppä (Chair), Professor, University of Helsinki and Helsinki University Hospital
Caroline Heckman, Research Director, University of Helsinki
Tuomas Mirtti, Professor, University of Helsinki and Helsinki University Hospital
Päivi Ojala, Professor, University of Helsinki
Esa Pitkänen, FIMM-EMBL Group Leader, University of Helsinki
Thomas Hackman, iCAN Patient and Citizen Advisory Board
Tiina Vesterinen, Managing Director, Finnish Cancer Institute
iCAN core
Helene Wahl, Satu Sankkila, Marketta Liljeström
iCANDOC
Mila Hyytinen, Piia-Riitta Karhemo
Contact
We are happy to answer your questions at ican-symposium@helsinki.fi